The crystal structure of protease Sapp1p from Candida parapsilosis in complex with the HIV protease inhibitor ritonavir

References

• Piacenti FJ. An update and review of antiretroviral therapy. Pharmacotherapy 2006;26:1111–1133.
   PubMed Web of Science ®Google Scholar
• Munro CA, Hube B. Anti-fungal therapy at the HAART of viral therapy. Trends Microbiol 2002;10:173–177.
   PubMed Web of Science ®Google Scholar
• Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003;67:400–428.
   PubMed Web of Science ®Google Scholar
• Hruskova-Heidingsfeldova O. Secreted proteins of Candida albicans. Front Biosci 2008;13:7227–7242.
   PubMed Web of Science ®Google Scholar
• Cassone A, De Bernardis F, Torosantucci A, Tacconelli E, Tumbarello M, Cauda R. In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors. J Infect Dis 1999;180:448–453.
   PubMed Web of Science ®Google Scholar
• Wurzner R, Bektic J, Lell CP, Fuchs A, Stoiber H, Speth C, Lass-Florl C, Borg-von Zepelin M, Dierich MP. HIV protease inhibitors attenuate adherence of Candida albicans to epithelial cells in vitro. FEMS Immunol Med Microbiol 2001;31:65–71.
   PubMedGoogle Scholar
• Schaller M, Bein M, Korting HC, Baur S, Hamm G, Monod M et al. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Infect Immun 2003;71:3227–3234.
   PubMed Web of Science ®Google Scholar
• Monod M, Borg-von Zepelin M, Meyer I, Thomssen R, Wurzner R, Sanglard D, Telenti A. HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol 1999;113:747–751.
   PubMed Web of Science ®Google Scholar
• Fallon K, Bausch K, Noonan J, Huguenel E, Tamburini P. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 1997;65:551–556.
   PubMed Web of Science ®Google Scholar
• Falkensammer B, Pilz G, Bektic J, Imwidthaya P, Jöhrer K, Speth C et al. Absent reduction by HIV protease inhibitors of Candida albicans adhesion to endothelial cells. Mycoses 2007;50:172–177.
   PubMed Web of Science ®Google Scholar
• Pichová I, Pavlícková L, Dostál J, Dolejsí E, Hrusková-Heidingsfeldová O, Weber J et al. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur J Biochem 2001;268:2669–2677.
   PubMedGoogle Scholar
• Dostál J, Hamal P, Pavlícková L, Soucek M, Ruml T, Pichová I et al. Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. J Clin Microbiol 2003;41:712–716.
   PubMed Web of Science ®Google Scholar
• Danner SA, Carr A, Leonard JM, Lehman LM, Gudiol F, Gonzales J et al. A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med 1995;333:1528–1533.
   PubMed Web of Science ®Google Scholar
• Baradkar VP, Mathur M, Kumar S. Hichrom candida agar for identification of Candida species. Indian J Pathol Microbiol 2010;53:93–95.
   PubMed Web of Science ®Google Scholar
• Back-Brito GN, Mota AJ, Vasconcellos TC, Querido SM, Jorge AO, Reis AS et al. Frequency of Candida spp. in the oral cavity of Brazilian HIV-positive patients and correlation with CD4 cell counts and viral load. Mycopathologia 2009;167:81–87.
   PubMed Web of Science ®Google Scholar
• Kempf DJ, Marsh KC, Denissen JF, Mcdonald E, Vasavanonda S, Flentge CA, Green BE, Fino L, Park CH, Kong XP, Wideburg NE, Saldivar A, Ruiz L, Kati WM, Sham HL, Robins T, Stewart KD, Hsu A, Plattner JJ, Leonard JM, Norbeck DW. ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. PNAS 1995;92:2484–2488.
   PubMed Web of Science ®Google Scholar
• Dostál J, Brynda J, Hrusková-Heidingsfeldová O, Sieglová I, Pichová I, Rezácová P. The crystal structure of the secreted aspartic protease 1 from Candida parapsilosis in complex with pepstatin A. J Struct Biol 2009;167:145–152.
   PubMed Web of Science ®Google Scholar
• Leslie AG. Integration of macromolecular diffraction data. Acta Crystallogr D Biol Crystallogr 1999;55:1696–1702.
   PubMedGoogle Scholar
• Evans P. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 2006;62:72–82.
   PubMedGoogle Scholar
• The CCP4 suite: programs for protein crystallography.Acta Crystallogr D Biol Crystallogr 1994;50:760–763.
   Google Scholar
• Vagin A, Teplyakov A. An approach to multi-copy search in molecular replacement. Acta Crystallogr D Biol Crystallogr 2000;56:1622–1624.
   PubMed Web of Science ®Google Scholar
• Murshudov GN, Skubák P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr 2011;67:355–367.
   PubMed Web of Science ®Google Scholar
• Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004;60:2126–2132.
   PubMed Web of Science ®Google Scholar
• Winn MD, Isupov MN, Murshudov GN. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr D Biol Crystallogr 2001;57:122–133.
   PubMedGoogle Scholar
• Lovell SC, Davis IW, Arendall WB 3rd, de Bakker PI, Word JM, Prisant MG et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 2003;50:437–450.
   PubMed Web of Science ®Google Scholar
• Lawrence MC, Colman PM. Shape complementarity at protein/protein interfaces. J Mol Biol 1993;234:946–950.
   PubMed Web of Science ®Google Scholar
• DeLano WL. 2002. The PyMOL Molecular Graphics System. DeLano Scientific LLC, San Carlos, CA, USA. Available from <http://www.pymol.org>.
   Google Scholar
• Betts MJ, Sternberg MJ. An analysis of conformational changes on protein-protein association: implications for predictive docking. Protein Eng 1999;12:271–283.
   PubMedGoogle Scholar
• Rinnová M, Hradilek M, Barinka C, Weber J, Soucek M, Vondrásek J et al. A picomolar inhibitor of resistant strains of human immunodeficiency virus protease identified by a combinatorial approach. Arch Biochem Biophys 2000;382:22–30.
   PubMed Web of Science ®Google Scholar
• Klabe RM, Bacheler LT, Ala PJ, Erickson-Viitanen S, Meek JL. Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency. Biochemistry 1998;37:8735–8742.
   PubMed Web of Science ®Google Scholar
• Brünger AT. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 1992;355:472–475.
   PubMed Web of Science ®Google Scholar